| PERIOD ENDING |
2-Oct-09 |
3-Jul-09 |
3-Apr-09 |
31-Dec-08 |
| Total Revenue |
5,569,000 |
5,909,000 |
5,050,000 |
5,237,000 |
| Cost of Revenue |
3,404,000 |
3,646,000 |
3,173,000 |
3,297,000 |
|
| Gross Profit |
2,165,000 |
2,263,000 |
1,877,000 |
1,940,000 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative |
1,701,000 |
1,714,000 |
1,636,000 |
1,703,000 |
| Non Recurring |
-
|
-
|
-
|
2,346,000 |
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss |
464,000 |
549,000 |
241,000 |
(2,109,000) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
2,000 |
4,000 |
1,000 |
(7,000) |
| Earnings Before Interest And Taxes |
466,000 |
553,000 |
242,000 |
(2,116,000) |
| Interest Expense |
140,000 |
145,000 |
156,000 |
153,000 |
| Income Before Tax |
326,000 |
408,000 |
86,000 |
(2,269,000) |
| Income Tax Expense |
79,000 |
95,000 |
25,000 |
(819,000) |
| Minority Interest |
-
|
-
|
-
|
-
|
| |
| Net Income From Continuing Ops |
247,000 |
313,000 |
61,000 |
(1,450,000) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income |
247,000 |
313,000 |
61,000 |
(1,450,000) |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares |
$247,000 |
$313,000 |
$61,000 |
($1,450,000) |
|
Help
Income Statement
Reuters offers more in-depth